FibroBiologics CYWC628 Diabetic Ulcer Trial Release
FibroBiologics releases CYWC628 drug for Phase 1/2 diabetic foot ulcer trial. The biotech holds 270+ patents. Clinical progress advances wound care.
Topic cluster
steady
1 source grouped by AFBytes in Economy
AFBytes briefing
Diabetic treatments cut healthcare costs for patients. Reduces amputations burdening families. Jobs in biotech expand.
What to watch next
- Await interim trial data releases for efficacy.